4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Vir Biotechnology, Inc. (VIR) operates in the Biotechnology industry and is headquartered in San Francisco, United States with about 367 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, VIR reported $66M in revenue and ($438M) in net income.
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.
Interactive charts & full statements → Open the VIR valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $66M | $64M | $40M | $1.6B |
| Gross Profit | $66M | $63M | $37M | $1.4B |
| Operating Income (EBIT) | ($480M) | ($552M) | ($671M) | $833M |
| Net Income | ($438M) | ($522M) | ($615M) | $516M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $64M | ($0M) | $1M | $2M | — |
| Gross Profit | — | $64M | ($0M) | $1M | $2M | $11M |
| Operating Income (EBIT) | ($132M) | ($48M) | ($173M) | ($119M) | ($140M) | — |
| Net Income | ($126M) | ($43M) | ($163M) | ($111M) | ($121M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.0B | $1.4B | $1.9B | $2.8B | — |
| Total Liabilities | $238M | $248M | $329M | $724M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VIR viewer.
About TickerBase · Data methodology & sources